effects [qlco]
Short-term [tmco]
Fenofibrate [orch, phsu]
treatment [ftcn]
Circulating [ftcn]
Marker [clna]
Inflammation [patf]
Haemostasis [ortf]
Patients [podg]
Impaired glucose tolerance [dsyn]
Context [fndg]
lowering [spco]
Lipid level [lbtr]
Peroxisome proliferator receptor alpha activator [phsu]
Activated [acty]
Fibrates [orch, phsu]
Favorable [qlco]
effects [qlco]
Contribute [acty]
Effectiveness [qlco]
Dyslipidaemia [dsyn]
diabetic [fndg]
Patients [podg]
Objective [inpr]
Objective [inpr]
Study [mnob]
IMPACT [gngm]
Short-term [tmco]
treatment [ftcn]
Fenofibrate [orch, phsu]
American Heart Association [hcro]
Step 1 [ftcn]
Diet [food]
Systemic [ftcn]
Inflammation [patf]
Haemostasis [ortf]
Monocyte [cell]
Secretory [celf]
function [phsf]
Relationship [qlco]
Metabolic [ftcn]
actions [ftcn]
Design [acty]
setting [ftcn]
participants [popg]
interventions [hlca]
prospective [resa]
randomized [resa]
placebo-controlled [resa]
Trial [resa]
Involving [ftcn]
Group [idcn]
Ambulatory [ftcn]
Patients [podg]
Impaired glucose tolerance [dsyn]
Diagnosed [fndg]
American Diabetes Association [pros]
criteria [inpr]
divided [ftcn]
Group [idcn]
simultaneously [tmco]
treated [topp]
American Heart Association [hcro]
Step 1 [ftcn]
Diet [food]
N 30 [orch, phsu]
micronized fenofibrate [orch, phsu]
mg/d [qnco]
N NOS [aapp, imft]
placebo [topp]
N 30 [orch, phsu]
Control Group [grup]
included [ftcn]
Age [orga]
Sex [orgf]
weight [orga]
matched [resa]
Subject [grup]
normal glucose [fndg]
Tolerance [fndg]
Six [qnco]
Patients [podg]
Subject [grup]
COMPLETED [qlco]
Study [mnob]
Main [qlco]
Outcome Measures [qnco]
Plasma [bdsu]
Marker [clna]
Inflammation [patf]
Haemostasis [ortf]
Monocyte [cell]
Release [hlca]
Cytokines [aapp, imft]
Measured [qlco]
Compared [acty]
Subject [grup]
normal glucose [fndg]
Tolerance [fndg]
Impaired glucose tolerance [dsyn]
Patients [podg]
Exhibit [inpr]
Plasma [bdsu]
level activity [fndg]
Fibrinogen [aapp, bacs, phsu]
Factor VII [aapp, bacs, phsu]
Plasminogen Activator Inhibitor 1 [aapp, bacs]
High sensitivity [lbpr]
C-reactive protein [aapp, imft]
oxidized low density lipoprotein [aapp, bacs]
Lipopolysaccharide [lipd]
Activated [acty]
Monocytes [cell]
Impaired glucose tolerance [dsyn]
Patients [podg]
Released [ftcn]
tnf alpha [aapp, imft]
IL-1 beta [aapp, imft]
IL6 [aapp, imft]
Monocyte Chemoattractant Protein-1 [aapp, imft]
Comparison [acty]
Monocytes [cell]
Subject [grup]
THIRTY-DAY [inpr]
treatment [ftcn]
Fenofibrate [orch, phsu]
American Heart Association [hcro]
Step 1 [ftcn]
Diet [food]
Improved [qlco]
lipid lipoprotein [aapp, lipd]
Profile [lbpr]
glucose metabolism [moft]
Reverse [idcn]
Abnormalities [cgab]
Favorable [qlco]
effects [qlco]
Fenofibrate [orch, phsu]
Plasma C-reactive protein [aapp]
High sensitivity [lbpr]
Monocyte [cell]
Release [hlca]
tnf alpha [aapp, imft]
IL-1 beta [aapp, imft]
IL6 [aapp, imft]
Monocyte Chemoattractant Protein-1 [aapp, imft]
Action [ftcn]
Plasma lipids [lbpr]
Improvement [cnce]
Insulin Sensitivity [patf]
free fatty acid [lipd]
Lower (action) [acty]
Conclusions [idcn]
Study [mnob]
Small [qnco]
Disturbance [qlco]
glucose metabolism [moft]
Marked [qlco]
Abnormalities [cgab]
Plasma [bdsu]
Marker [clna]
Inflammation [patf]
Haemostasis [ortf]
Monocyte [cell]
Secretory [celf]
function [phsf]
Fenofibrate [orch, phsu]
Exhibit [inpr]
effects [qlco]
Patients [podg]
Impaired glucose tolerance [dsyn]
